Standard Strategies Inc. is a venture capital firm focused on early-stage investments in plant medicine, technology, wellness, and genomics. While the company has a strong liquidity position with a current ratio of 3.45 and manageable debt levels (0.31 debt/equity), it faces concerns with negative returns on equity (-6.6%) and assets (-4.7%). The low stock price of $0.01 and market cap of $771.92K indicate potential undervaluation, but the negative financial metrics raise questions about profitability and growth prospects. Overall, the firm shows promise but requires careful monitoring of its financial health.
Loading financial metrics...
Company posted a loss of $-1.1M over the last year, representing Infinity% of revenue.
Operating cash flow has been negative for 3 consecutive quarters, burning $199K over the last year.
Fortress balance sheet: cash covers total debt 4.5×, providing significant financial flexibility.
Excellent liquidity with current ratio of 3.5x ensures operational stability.
Valuation, risk assessment, competitive positioning, and key insights — all in one report.
Other Software - Infrastructure companies of a similar size
Based on 2025-Q2 (April 30, 2025)